Fatal acute lymphoblastic leukemia in mice transgenic for B cell-restricted bcl-XL and c-myc

Journal of Immunology

Volumn 172, Issue 11, 2004, Pages 6684-6691

  Swanson, Penelope J ^a   Kuslak, Sheri L ^a   Fang, Wei ^a   Tze, Lina ^a   Gaffney, Patrick ^a   Selby, Scott ^a   Hippen, Keli L ^a   Nunez, Gabriel ^b   Sidman, Charles L ^c   Behrens, Timothy W ^a,d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7; LYMPHOCYTE SURFACE MARKER; PROTEIN BCL XL;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FATALITY; GENE EXPRESSION; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; IN VITRO STUDY; LEUKEMIA CELL; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; SPLEEN; STEM CELL; TRANSGENIC MOUSE; TUMOR CELL;

EID: 2442646523     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.11.6684     Document Type: Article

References (51)

1. Hayward, W. S., B. G. Neel, and S. M. Astrin. 1981. Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature 290:475.
2. Dalla-Favera, R., M. Bregni, J. Erikson, D. Patterson, R. C. Gallo, and C. M. Croce. 1982. Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA 79:7824.
3. Shen-Ong, G. L., E. J. Keath, S. P. Piccoli, and M. D. Cole. 1982. Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas. Cell 31:443.
4. Bouchard, C., P. Staller, and M. Eilers. 1998. Control of cell proliferation by Myc. Trends Cell Biol. 8:202.
5. Hurlin, P. J., D. E. Ayer, C. Grandori, and R. N. Eisenman. 1994. The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes. Cold Spring Harb. Symp. Quant. Biol. 59:109.
6. Zou, X., Y. Lin, S. Rudchenko, and K. Calame. 1997. Positive and negative regulation of c-Myc transcription. Curr. Top. Microbiol. Immunol. 224:57.
7. Bello-Fernandez, C., G. Packham, and J. L. Cleveland. 1993. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA 90:7804.
8. Galaktionov, K., X. Chen, and D. Beach. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511.
9. Thompson, E. B. 1998. The many roles of c-Myc in apoptosis. Annu. Rev. Physiol. 60:575.
10. Zornig, M., and G. I. Evan. 1996. Cell cycle: on target with Myc. Curr Biol. 6:1553.
11. Bissonnette, R. P., F. Echeverri, A. Mahboubi, and D. R. Green. 1992. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552.
12. Fanidi, A., E. A. Harrington, and G. I. Evan. 1992. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359:554.
13. Adams, J. M., A. W. Harris, C. A. Pinkert, L. M. Corcoran, W. S. Alexander, S. Cory, R. D. Palmiter, and R. L. Brinster. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318:533.
14. Langdon, W. Y., A. W. Harris, S. Cory, and J. M. Adams. 1986. The c-myc oncogene perturbs B lymphocyte development in E-μ-myc transgenic mice. Cell 47:11.
15. Eischen, C. M., J. D. Weber, M. F. Roussel, C. J. Sherr, and J. L. Cleveland. 1999. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagnesis. Genes Dev. 13:2658.
16. Alexander, W. S., J. M. Adams, and S. Cory. 1989. Oncogene cooperation in lymphocyte transformation: malignant conversion of Eμ-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v- raf but not v-abl. Mol. Cell. Biol. 9:67.
17. Strasser, A., A. W. Harris, M. L. Bath, and S. Cory, 1990. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348:331.
18. Strasser, A., A. G. Elefanty, A. W. Harris, and S. Cory. 1996. Progenitor tumours from Eμ-bcl-2-myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival. EMBO J. 15:3823.
19. Boise, L. H., M. Gonzalez-Garcia, C. E. Postema, L. Ding, T. Lindsten, L. A. Turka, X. Mao, G. Nunez, and C. B. Thompson. 1993. bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597.
20. Gross, A., J. M. McDonnell, and S. J. Korsmeyer, 1999. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 13.1899.
21. Fang, W., J. J. Rivard, D. L. Mueller, and T. W. Behrens. 1994. Cloning and molecular characterization of mouse bcl-x in B and T lymphocytes. J. Immunol. 153:4388.
22. L transgene. Immunity 4:291.
23. L displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J. Exp. Med. 182:1973.
24. Grillot, D. A. M., R. Merino, J. C. Pena, W. C. Fanslow, F. D. Finkelman, C. B. Thompson, and G. Nunez. 1996. Bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J. Exp. Med. 183:381.
25. L escape negative selection and are tolerized by clonal anergy and receptor editing. Immunity 9:35.
26. L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res. 55:2576.
27. Olopade, O. I., M. O. Adeyanju, A. R. Safa, F. Hagos, R. Mick, C. B. Thompson, and W. M. Recant. 1997. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J. Sci. Am. 3:230.
28. Tang, D. G., L. Li, D. P. Chopra, and A. T. Porter. 1998. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins. Cancer Res. 58:3466.
29. L is heterogenously expressed by acute myeloblastic leukaemia cells and is associated with autonomous growth in vitro and with P-glycoprotein expression. Leukemia 11:945.
30. Schlaifer, D., M. March, S. Krajewski, G. Laurent, J. Pris, G. Delsol, J. C. Reed, and P. Brousset. 1995. High expression of the bcl-x gene in Reed-Sternberg cells of Hodgkin's disease. Blood 85:2671.
31. Hermann, M., H. J. Scholman, T. Marafioti, H. Stein, and F. Schriever. 1997. Differential expression of apoptosis, Bcl-x and c-Myc in normal and malignant lymphoid tissues. Eur. J. Haematol. 59:20.
32. Schlaifer, D., S. Krajewski, S. Galoin, H. F. Rigal, G. Laurent, P. Massip, J. Pris, G. Delsol, J. C. Reed, and P. Brousset. 1996. Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infection. Am. J. Pathol. 149:177.
33. Tu, Y., S. Renner, F. Xu, A. Fleishman, J. Taylor, J. Weisz, R. Vescio, M. Rettig, J. Berenson, S. Krajewski, et al. 1998. BCL-X expression in multiple myeloma: possible indicator of chemoresistance. Cancer Res. 58:256.
34. L by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes Dev. 12:2475.
35. Hippen, K. L., L. E. Tze, and T. W. Behrens. 2000. CD5 maintains tolerance in anergic B cells. J. Exp. Med. 191:883.
36. Tze, L. E., E. A. Baness, K. L. Hippen, and T. W. Behrens. 2000. Ig light chain receptor editing in anergic B cells. J. Immunol. 165:6796.
37. Melamed, D., J. A. Kench, K. Grabstein, A. Rolink, and D. Nemazee. 1997. A functional B cell receptor transgene allows IL-7 independent maturation of B cell precursors. J. Immunol. 159:1233.
38. Schlissel, M. S., L. M. Corcoran, and D. Baltimore. 1991. Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription. J. Exp. Med. 173:711.
39. Li, Y. S., R. Wasserman, K. Hayakawa, and R. R. Hardy. 1996. Identification of the earliest B lineage stage in mouse bone marrow. Immunity 5:527.
40. Cumano, A., K. Dorshkind, S. Gillis, and C. J. Paige. 1990. The influence of IL-7 and S-17 stromal cells on B cell development. Eur. J. Immunol. 20:2183.
41. Cory, S. 1995. Regulation of lymphocyte survival by the bcl-2 gene family. Annu. Rev. Immunol. 13:513.
42. Haddad, M. G., J. F. Silverman, V. V. Joshi, and K. R. Geisinger. 1995. Effusion cytology in Burkitt's lymphoma. Diagn. Cytopathol. 12:3.
43. Loffler, H., and W. Gassmann. 1994. Morphology and cytochemistry of acute lymphoblastic leukaemia. Baillieres Clin. Haematol. 7:263.
44. Pui, C. H., and W. E. Evans. 1998. Acute lymphoblastic leukemia. N. Engl. J. Med. 339:605.
45. Spangrude, G. S., S. Heimfeld, and I. Weissman. 1988. Purification and characterization of mouse hematopoetic stem cells. Science 241:58.
46. L permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells. J. Exp. Med. 187:1081.
47. Veis, D. J., C. M. Sorenson, J. R. Shutter, and S. J. Korsmeyer. 1993. bcl-2 deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229.
48. Ma, A., J. C. Pena, B. Chang, E. Margosian, L. Davidson, F. W. Alt, and C. B. Thompson. 1995. Bcl-x regulates survival of double positive thymocytes. Proc. Natl. Acad. Sci. USA 92:4763.
49. Stoddart, A., H. E. Fleming, and C. J. Paige. 2000. The role of the pre-BCR, the interleukin-7 receptor, and homotypic interactions during B-cell development. Immunol. Rev. 175.
50. L or bcl-2 is bypassed during lymphomagenesis. Mol. Cell. Biol. 21:5063.
51. Grumont, R. J., I. J. Rourk, and S. Gerondakis. 1999. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev. 13:400.